Zosano Pharma Corporation (ZSAN): Price and Financial Metrics
ZSAN Price/Volume Stats
| Current price | $0.56 | 52-week high | $37.45 |
| Prev. close | $0.52 | 52-week low | $0.46 |
| Day low | $0.46 | Volume | 1,155,000 |
| Day high | $0.64 | Avg. volume | 425,375 |
| 50-day MA | $2.52 | Dividend yield | N/A |
| 200-day MA | $13.86 | Market Cap | 2.73M |
ZSAN Stock Price Chart Interactive Chart >
Zosano Pharma Corporation (ZSAN) Company Bio
Zosano Pharma Corporation provides biopharmaceutical products and services. The Company specializes in biopharmaceuticals, peptides, small water soluble molecules, monoclonal antibodies, and vaccines for the treatment of severe osteoporosis.
Latest ZSAN News From Around the Web
Below are the latest news stories about Zosano Pharma Corp that investors may wish to consider to help them evaluate ZSAN as an investment opportunity.
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on TuesdayWith the long weekend over it's time to start another week of trading with the biggest pre-market stock movers for Tuesday! |
FDA Rejects Zosano Pharma's Application For Zolmitriptan Microneedle System Again, Shares PlungeThe FDA has issued a response letter to Zosano Pharma Corp (NASDAQ: ZSAN) regarding its resubmission of the 505(b)(2) New Drug Application for M207 (zolmitriptan microneedle system). The response letter stated that the FDA did not consider the resubmitted M207 application a complete response to the deficiencies identified in the FDA’s October 2020 Complete Response Letter. The FDA will not begin a substantive review of the application until a complete response is received. The FDA’s response let |
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on WednesdayGood morning, investor! |
Zosano Pharma Announces Pricing of $15.4 Million Public Offering of Common Stock and WarrantsFREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced the pricing of its previously announced underwritten public offering of 51,250,000 units, each consisting of one share of common stock and one warrant to purchase one share of common stock, at a public offering price of $0.30 per unit. The warrants have an exercise price of $0.30 per share, are immediately exercisable and will expire five years f |
Zosano Pharma Announces Proposed Public Offering of Common Stock and WarrantsFREMONT, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) -- Zosano Pharma Corporation (Nasdaq:ZSAN), a clinical-stage biopharmaceutical company, today announced that it is commencing an underwritten public offering of units consisting of shares of common stock and warrants to purchase common stock. All of the units in the offering are to be sold by Zosano. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or the actu |
ZSAN Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | -98.29% |
| 5-year | -99.53% |
| YTD | N/A |
| 2023 | N/A |
| 2022 | 0.00% |
| 2021 | -10.83% |
| 2020 | -65.32% |
| 2019 | -28.30% |
Loading social stream, please wait...